Practice Areas - Equity Capital Markets Law Firms and Lawyers
Deal Date: | 30-03-2015 | Practice Area: | Equity Capital Markets |
Deal Title: | ZS Pharma, Inc. Follow-On Offering of Common Stock | Industry: | Pharmaceuticals & Biotechnology |
Description: |
Davis Polk advised the underwriters in connection with the public offering of 4,015,939 shares of common stock of ZS Pharma, Inc. at USD46.25 per share, for gross proceeds of USD185.7 million. ZS Pharma's common stock is traded on the NASDAQ Global Market under the symbol ZSPH.
The Davis Polk corporate team included partner Alan F. Denenberg and associates Peter M. Lamb, Sarah Ahmad and Mohammad Ali.
|
||
Financial Center: | Silicon Valley | Value: | 100.01-500.00 |
Advised Party: | Underwriter | Law Firm | Davis Polk |
Issuer Jurisdiction - | United States | Listing Jurisdiction - | United States |
Classification: |
Secondary Offerings and Placings NASDAQ: |
Lawyer | Alan F Denenberg |